Abstract Library

#2913 The Predictive Value of Neuroendocrine Transcript Analysis in Daily Practice: An Independent ‘Real-World’ Validation Study

Introduction: Assessment of disease status remains the fundamental basis in the management of gastro-entero-pancreatic neuro-endocrine tumors (GEPNETs). Circulating molecular information might be used as a liquid biopsy to predict its clinical course.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: van Treijen M

Authors: van Treijen M, van der Zee D, Heeres B, Staal F, Vriens M,

Keywords: biomarker, progression-free survival, gastro-entero-pancreatic neuroendocrine tumours,

#2748 CT-Based Radiomics for Prediction of Outcome after Somatostatin Analogues in Patients with Liver Metastases of a Neuroendocrine Tumor: An Exploratory Study

Introduction: Response evaluation and prediction of outcome of a neuroendocrine tumor (NET) remains difficult.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Staal F, Taghavi M, van Treijen M, Tesselaar M, Beets-Tan R,

Keywords: Radiomics, CT, Liver metastases, Response, Outcome prediction,

#697 Grading NET: Mitosis and Ki-67 conditio sine qua non?

Introduction: The latest WHO classification for neuroendocrine tumors (NET) defines their grade according to Ki-67 and mitotic index. However, as both parameters are markers for a different part of the cell cycle, their values might not lead to the same grade.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: van Velthuysen M

Authors: Van Velthuysen M, Korse T, Van der Pol A, Tesselaar M, Taal B,

Keywords: grade, Ki-67, mitosis, NET,

#206 Diverging Incidence and Survival Trends for Neuroendocrine Tumors due to Histological Grade

Introduction: Epidemiological data of NET are mostly classified according to the primary site of the tumor. However, a pathologic classification, irrespective of primary site, might be more informative.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Korse C, Taal B, van Velthuysen M, Visser O,

Keywords: neuroendocrine tumors, epidemiology, survival, pathology, classification,

#77 Angiogenesis markers after hepatic artery embolization of liver metastases in patients with neuroendocrine tumors

Introduction: In the event of diffuse hepatic metastases, hepatic artery embolization (HAE) can be a successful treatment option in patients with well-differentiated neuroendocrine tumors (WNET). Although there are suggestions of activation of the angiogenesis by HAE, no information is available about the development of growth factors caused by vascular obstruction with embolization.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Korse C, Bonfrer J, Taal B,

Keywords: neuroendocrine tumors, hepatic artery embolization, angiogenesis, necrosis, VEGF, Endothelin, pro-Endothelin, cytokeratin, MonoTotal,